Dr. med. Uwe Auf der Strasse

    Quellen 

1)  Aguirre-Cruz L., Calderon M., and Sotelo J.:    Colchicine Decreases the Infection by Toxoplasma gondii in Cultured Glia        Cells. The Journal of Parasitology Vol. 82, No. 2 (Apr., 1996), pp. 325-327

 

2)  Alavi S.M., Alavi L. :    Treatment of  toxoplasmic lymphadenitis with co-trimoxazole: double-blind, randomized clinical          trial.  Int J Infect Dis. 2010 Sep;14 Suppl 3:e67-9. doi: 10.1016/j.ijid.2009.11.015. Epub 2010 Mar 2.

 

3)  Aliberti, J., D. Jankovic, and A. Sher. 2004.     Turning it on and off:  regulation of  dendritic cell  function in Toxoplasma          gondii infection.  Immunol. Rev.201:26–34.


4)  Aramini J.J., Stephen C., Dubai J.P.,  Engelstoft C.,  Schwantje H., Ribble C.S. Potential contamination of drinking water          with Toxoplasma gondii oocysts. Epidemic Infect. 1999 April; 122(2):305-15

 

5)  Assimakopoulos, S.F.,  Stamouli V.,  Dimitropoulou D.,  Spiliopoulou A.,  Panos G., Anastassiou M., Marangos M., Spilio-          poulou I.:  Toxoplasma gondii meningoencephalitis without cerebral MRI findings in a patient with ulcerative colitis

     under immunsuppressive treatment.  Infection 5/2015

 

6)  Bhadra Rajarshi, Khan Imtiaz A. 2012:  Redefining Chronic Toxoplasmosis - A T Cell Exhaustion Perspective.  Depart-            ment of Microbiology,  Immunology and  Tropical Medicine,  George Washington University,  Washington, D.C., United             States of America PLoS Pathogens, 8(10), article number 1002903.

 

7)  Behan W.M.H., Behan P., P.O., Draper I.T. & Williams H., (1983).    Does  Toxoplasma gondii cause  polymyositis ?  Acta              neuropathologica, 61, 246-52

 

8)  Berverly J.K.A, Beattie, C.P. (1958)  Glandular toxoplasmosis. A survey of 30 cases.  Lancet, ii, 379-84

9)  Blais J., Tardif C., and Chamberlain S.:   Effect of clindamycin on  intracellular  replication,  protein  synthesis,  and                 infectivity of Toxoplasma gondii.  Antimicrob Agents Chemother. 1993 Dec; 37(12): 2571–2577.

 

10) Bretagne S.:  Molecular diagnostics in  clinical parasitology and mycology: l imits of the current polymerase chain                reaction (PCR) assays and interest of the real-time PCR assays. Clin Microbiol Infect 2003, 9:505-11.

 

11) Carme B., Bissuel F., Ajzenberg D., Bouyne R., Aznar C., Demar M., Louvel D., Bourbigot M., Peneau C., Neron P. and                 Darde M.L: Severe Acquired Toxoplasmosis in Immunocompetent Adult Patients in French Guiana. J Clin Microbiol.

      2002 Nov; 40(11): 4037–4044.

 

12) Coccaro E.F., Royce Lee, Maureen W.Groer, Adem Can, Mary Coussons-Read and T.T. Postolache:  Toxoplasma gondii             Infection: Relationship With Aggression in Psychiatric subjects. The Journal of Clinical Psychiatry 2016; 77 (3): 334-341

 

13) Colinot D.L., Garbuz T., Wang L., Rice S.E., Sullivan W.J. Jr., Arrizabalanga G., JerdeT.J.:  The common parasite                         Toxoplasma gondii induces prostatic inflammation and microglandular hyperplasia in a mouse model.  Prostrate, 2017       Jul;77(10):1066-1075. doi: 10.1002/pros.23362. Epub 2017 May 12.

 

14) Cook A.J.C., Gilbert R.E., Buffolano W., Zuffrey J., Petersen E., Jenum P.A., Foulon W., Semprini A.E., Dunn D.T.                            & European Research Network on Congenital Toxoplasmosis Sources of Toxoplasma infection in pregnant women:              European multicentre case control study BMJ 2015, Juli; 321, 142-147

 

15) Courret N, Darche S, Sonigo P, Milon G, Buzoni-Gâtel D, Tardieux I. : CD11c- and CD11b-expressing mouse leukocytes            transport single Toxoplasma gondii tachyzoites to the brain. Blood 2006 Jan 1; 107(1): 309–316.

 

16) Cuturic M., Hayat G.R., Vogler C.A., Velasques A.  Toxoplasmic polymyositis revisited: case report and review of                        literature. Neuromuscul Disord. 1997 Sep; 7 (6-7): 390-6

 

17) Dalimi A. and Abdoli A.  Latent Toxoplasmosis and Human. Iran J Parasitol. 2012; 7(1): 1-17

 

18) Dannemann B., McCutchan J.A., Israelski D., et al. Treatment of toxoplasmic encephalitis in Patients with AIDS.  A                 randomized trial comparing pyrimthamine plus Clindamycin to Pyrimethamin plus Sulfa-diazine.  Ann Intern Med

      1992, 116: 33-43

 

19) Denkers, E. Y., and B. A. Butcher. 2005.  Sabotage and exploitation in macrophages parasitized by intracellular                       protozoans. Trends Parasitol. 21: 35–41.

 

20) Desmonts G., Naot Y., Remington J.S.  Immunoglobulin M immuno-sorbent agglutination assay for diagnosis of                     infectious diseases. Diagnosis of acute congenital and acquired Toxoplasma infections.  J. clin Microbiol. 1981;

      14: 544-549

 

21) Di Cristina, M., Dou, Z., Lunghi, M., Kannan, G., Huynh, M. H., McGovern, O. L.,  Carruthers, V. B. (2017). Toxoplasma                   depends on lysosomal consumption of autophagosomes for persistent infection. Nature Microbiology,2, [17096].

      DOI: 10.1038/ nmicrobiol. 2017.96

 

22) Dickerson F., Wilcox H.C., Adamos M., Katsafanas E., Khushalani S., Origoni A., Savage C., Schweinfurth L., Stallings C.,         Sweeney K., Yolken R.: Suicide attempts and markers of immune response in individuals with serious mental illness.  

      J Psychiatr Res. 2017 Apr;87:37-43. Doi: 10.1016/ j.jpsychires.2016.11.011. Epub 2016 Dec 1.

 

23) Dogan N., Kabukcuoglu S., Vardareli E.  Toxoplasmic Hepatitis in an Immunocompetent Patient.  Türkiye Parazitoloji             Dergisi, 31 (4): 260-263, 2007

 

24) Dubey J.P., Gamble H.R., Hill D., Sreekumar C., Romand S., Thulliez P.:  High prevalence of viable Toxoplasma Gondii in          market weight pigs from a farm in Massachusetts.  J. Parasitol., 88(6), 2002, pp. 1234–1238

 

25) Eyles D., Coleman N.  Synergistic effect of sulphadiazine and daraprim against experimental toxoplasmosis in the                mouse. Antibiot. Chemother. 1953; 3: 483-90

 

26) Ferguson D.J., Hutchinson W.M. Petersen E. 1989  Tissue cyst rupture in mice chronically infected with Toxoplasma             gondii. An Immunocytochemical and ultrastructural study.  Parasitol Res 75: 599 – 603

 

27) Fischer H.G., Nitzen B., Reichmann G., Haddig u.  Cytokin responses induced by Toxoplasma gondii in atrocytes and             microglial cells Eur J Immunol 1997 Jun;27(6):1539-48.

 

28) Flegr, J. (2007). Effects of Toxoplasma on human behavior. Schizophr. Bull. 33, 757–760.

 

29) Flegr J.:  Influence of latent Toxoplasma infection on human personality, physiology and morphology: pros and cons of       the Toxoplasma-human model in studying the manipulation hypothesis. J. Exp. Biol. 2013; 216 (Pt 1): 127 -33

 

30) Flegr J, Escudero DQ. Impaired health status and increased incidence of diseases in Toxoplasma-seropositive subjects        - an explorative cross-sectional study. Parasitology 2016; 143: 1974-1989.

 

31) Jaroslav Flegr, Joseph Prandota, Michaela Sovicˇkova ́, Zafar H. Israili:  Toxoplasmosis – A Global Threat. Correlation of       Latent Toxoplasmosis with Specific Disease Burden in a Set of 88 Countries. PloS One 2014 Mar 24;9(3):e90203. doi:           10.1371/journal.pone.0090203. eCollection 2014.

 

32) Frenkel J.K.:  Adoptive Immunity to Intracellular Infection.   J Immunol June 1, 1967, 98 (6) 1309-1319

 

33) Frenkel J.K., Smith D.D.: Immunization of cats against shedding of Toxoplasma oocysts. J. Parasitol. 1982

      Oct;68(5):744-8.

 

34) Ganji M., Tan A., Maitar, Michael, Weldon-Linne, M., Weisenberg E., and Douglas P.R.(2003) Gastric Toxoplasmosis in a           Patient With Acquired Immunodeficiency Syndrome A Case Report and Review of the Literature. Archives of Pathology       & Lab Med: June 2003, Vol. 127, No. 6, pp. 732-734.

 

35) Gigley, J.P., Bhadra R., Khan I.A.  CD8 T Cells and Toxoplasma gondii: A New Paradigm  Journal of Parasitology                       Research Volume 2011 (2011) Article ID 243796, 9 pages

 

36) Gras L., Gilbert R.E., Wallon M., Peyron F., Cortina-Borja M.: Dura-tion of the IgM response in women acquiring                       Toxoplasma gondii during pregnancy: implications for clinical practice and cross-sectional incidence studies.                       Epidemie Infect. 2004 Jun; 132(3): 541-548

 

37) Greenlee J.E., Johnson W.D., Jr, Campa, J.F., Adelman L.S., Sande M.A.:  Adult toxoplasmosis presenting as

      polymyositis and cerebellar ataxia. Ann Intern Med. 1975; 82: 367-371

 

38) Grigg et al., 2001:  Experimentally induced sexual recombination in the cat  Science 294, 161-5

 

39) Havlicek J., Gasova Z.G., Smith A.P., Zvara K., Flegr J.  Decrease of psychomotor performance in subjects with latent             "asymptomatic" toxoplasmosis.  Parasitology 2001 May; 122(Pt 5): 515-20

 

40) Hökelek M. MD, PhD; 2015 Chief Editor: Michael Stuart Bronze, MD: Toxoplasmosis Medication In: Medscape Drugs &           Diseases

 

41) Helieh S. Oz, DVM, PhD, AGAF:  Toxoplasma gondii (Toxoplasmosis) Authors, Second Edition: Montoya, J.G, Couvreur J.,         Leport, C. In: antimicrobiobe.org

 

42) Hermes G., Ajioka J., Kelly K., Mui E., Roberts F., Kasza K., Mayr T., Kirisits M., Wollmann R., Ferguson D.,  Roberts C.,              Hwang J., Trendler T., Kennan R., Suzuki Y., Reardon C., Hickey W., Chen L., McLeod R.: Neurological and behavioral                abnormalities, ventricular dilatation, altered cellular functions, inflammation, and neuronal injury in brains of mice

      due to common, persistent, parasitic infection.  Journal of Neuroinflammation. 2008, 5:48 doi:10.1186/1742-2094-5-48

 

43) Herrmann D.C., Pantchev N., Globokar Vrhovec M., Barutzki D., Wilking H., Fröhlich A., Lüder C.G.K., F.J. Conraths F.J.,             Schares G.: Atypical Toxoplasma gondii genotypes identified in oocysts shed by cats in Germany. International Journal

      for Parasitology 40 (2010) 285–292

 

44) Hill D., Dubey J.P.:  Toxopasma gondii: transmission, diagnosis and prevention  Clin Microbiol Infect. 2002; 8: 634-640

 

45) Ho-Yen D.O. :  Toxoplasmosis in humans. J Roy Soc Med 1990; 83: 571-2

 

46) Ho-Yen D.O., Joss A.W.L., Balfour A.H., Smyth E.T.M., Baird D., Chatterton J.M.W.:  Use of the polymerase chain reaction         to detect Toxoplasma gondii in human blood samples.  J Clin Pathol 1992; 45: 910-913

 

47) Janků, J., 1923. Pathogenesis and pathologic anatomy of the “congenital coloboma” of the macula lutea in an eye of             normal size, with microscopic detection of parasites in the retina. Cas Lek Ses. 1923, 62: 1021-1027.

 

48) Jacobs L.:  The occurrence of Toxoplasma infection in the absence of demonstrable antibodies In book: Proceedings

      of the first international Congress of Parasitology

 

49) Jean M., Chatterton W., McDonagh S., Spence Neil and Ho-Yen Darrel-O.  Changes in Toxoplasma diagnosis Journal of         Medical Micro-biology 2011, 60 (Pt 12): 1762-1766

 

50) Johnson Alan P. Methicillin-resistant Staphylococcus aureus: the Euro-pean landscape J.Antimicrobial Chemotherapy,         Volume 66, Issue suppl 4, 1 May 2011, Pages iv43–iv48

 

51) Kabelitz, H.J.:  Abdominelle Symptome bei postnatal erworbener Toxo-plasmose.  Deutsche medizinische                             Wochenschrift 1959 Vol.84 No.31 pp.1379-84, 1404 ref.17

 

52) Kotula A.W., Dubey J.P., Sharar A.K., Andrews C.D., Shen S.K., Lindsay D.S.:  Effect of Freezing on Infectivity of                         Toxoplasma gondii Tissue Cysts in Pork. J Food Prot. 1991;54:687-90.

 

53) Kuruca L , Klun I., Uzelac A., Nicolic A., Bobic B., Simin S., Lalo-sevic V., Lalosevic D., Djurkovic-Djakovic O.: Detection of         Toxoplasma gondii in naturally infected domestic pigs in Northern Serbia. Parasitol Res. 2017 Nov;116(11):3117-3123.

      doi: 10.1007/s00436-017-5623-7. Epub 2017 Sep 27.

 

54) Leal, F.E., Cavazanna, C.S., de Andrale,H.F.Jr., Galisteo, A.J.Jr, de Mendonca, J.S., Kallas, E.G.,Toxoplasma gondii                     Pneumonia in Immuno-competent Subjects: Case Report and Review Clinical Infectious Diseases, Volume 44, Issue 6,

      15 March 2007, Pages e62–e66

 

55) Luft, B.J. & Remington J.S. (1985).  Toxoplasmosis of the central nervous system.  Current Clinical Topics in Infectious         Diseases, ed J.S. Remington, M.n. Swartz, pp. 315-58. New York: McGraw-Hill

 

56) Mavin S., Ashburn D., Chatterton J.M.W., Evans R., Joss A.W.L. and Ho-Yen D.O. (2000)Patterns of Toxoplasma infection         during 1996-1999.  Scieh Wkly Rep 34, 278-280

 

57) Montazeri M.,  Mehrzadi S.,  Sharif M.,  Sarvi S., Shahdin S., Daryani A.:  Activities of  anti-Toxoplasma drugs and                    compounds against tissue cysts in the last three decades (1987 to 2017), a systematic review. Parasitol research 

      2018 Oct;117(10):3045-3057. doi: 10.1007/s00436-018-6027-z. Epub 2018 Aug 8.

 

58) Montoya J.G., Jordan R. Lingamneni S. Berry G.J., Remington J.S. : Toxoplasmic myokarditis and polymyositis in                   patients with acquired toxoplasmosis diagnosed during life Clin Infect Dis. 1997; 24 676-683

 

59) Montoya J.M, Liesenfeld O. : Toxoplasmosis. Lancet. 2004; 363: 1965-1976

 

60) Naviaux, Robert K. Naviaux, Jane C., Li, Kefeng, Bright, A. Taylor, Alaynick, William A. , Wang, Lin, Baxter, Asha, Nathan,         Neil, Anderson. Wayne and Gordon, Eric: Metabolic features of chronic fatigue syndrome PNAS 2016 September,

      113 (37) E5472-E5480.

 

61) Nicolle C, Manceaux L. : Sur un protozoaire nouveau du gondi. C R Seances Acad Sci. 1909;148:369–372.

 

62) Nilamadhab Kar, Baikunthanath Misra: Toxoplasma seropositivity and depression: case report  BMC Psychiatry

      2004 4:1

 

63) Paspalaki P., E. Mihailidou, M. Bitsori, D. Tsagkaraki, E. Mantzou-ranis:  Polymyositis and myocarditis associated with           acquired toxoplasmosis in an immunocompetent girl.  Department of Pediatrics, University General Hospital,                         University of Crete, School of Health Science. BMC Musculoskelet Disord. 2001; 2: 8. Published online 2001 Nov 20.

 

64) Pappas G., Roussos N. & Falagas M.E. (2009) :  Toxoplasmosis snapshots: global status of Toxoplasma gondii                          seroprevalence and implications for pregnantcy and congenital toxoplasmosis Int J Parasitol 39, 1385-1394

 

65) Pernas L, Adomako-Ankomah Y, Shastri AJ, Ewald SE, Treeck M, Boyle JP, Boothroyd JC: Toxoplasma effector MAF1             mediates recruitment of host mitochondria and impacts the host response.  PLoS Biol. 2014 Apr; 12(4):e1001845.

 

66) Prusa A.R., Hayde M., Pollak A., Herkner K.R.,Kasper D.C.: Evaluation of the Liaison Automated Testing System for                 Diagnosis of Congenital Toxoplasmosis. Clin Vaccine Immunol. 2012 Nov; 19(11): 1859-1863

 

67) Prusa A.R., Kasper D.C., Pollak A., Gleiss A., Waldhoer T., Hayde M.:  The Austrian Toxoplasmosis Register, 1992–                   2008  in: Clinical Infectious Diseases, Volume 60, Issue 2, 15 January 2015, Pages e4–e10,

 

68) Remington J.S., Mc Leod R., Thulliez P. et al.: Toxoplasmosis. In: Infectious Diseases of the Fetus an Newborn infant,

      WB Saunders; 2001 pp 205 – 346 Editors Remington J.S., Klein J.

 

69) Remington J.S, Miller M.J., Brownlee I.E.  IgM antibodies in acute Toxoplasmosis. II Prevalence and significance in                 aquired cases. J. Lab Clin Med. 1968; 71 855-866 (PubMed)

 

70) Remington J.S.:  Toxoplasmosis in the adult. Bull N Y Acad Med. 1974; 50: 211-227

 

71) Sabin A.B., Feldman H.A.1948. Dyes as microchemical indicators of a new immunity phenomenon affecting a                       protozoon parasite (Toxoplasma). Science 108: 660-663.

 

72) Schares G., Herrmann, D.C., Pantchev N., Globokar Vrhovec M., Barutzki D., Wilking H., Fröhlich A., Leder C.G.K.,

       und Conrads F.J. : Erster Nachweis atypischer Toxoplasma gondii - Genotypen in Deutschland In: ToxoNet 01,                        www.zoonose.net 

 

73) Schölkopf, M.:  Das Gesundheitswesen im internationalen Vergleich.  Gesundheitssystemvergleich und die

       europäische Gesundheitspolitik

 

74) Seon-Kyeong Kim and John C. Boothroyd:  Stage-Specific Expression of Surface Antigens by Toxoplasma gondii

       as a Mechanism to Facilitate Parasite Persistence J. Clin Immunol 2005; 174:8038-8048

 

75) Sharpe, M.C., Archard L., Banatvala J., Borysiewicz l.K., Clare A.W., David A., Edwards R., Hawton K.E.H et al (1991):               Chronic fatigue Syndrom: Guidelines for research  Journal of the Royal Society Medicine, 84, 115-21

 

76) Sinai, A. P., and K. A. Joiner. 1997.  Safe haven: the cell biology of nonfusogenic pathogen vacuoles. Annu. Rev.                       Microbiol. 51: 415–462.

 

77) Smith J.E., Mc Neil G., Zhang Y.W., Dutton G., Biswas-Hughes G., Applefordt P.:  Serological Recognition of Toxoplasma            gondii Cyst Antigens. Curr Top Microbiol Immunol. 1996;219:67-73.

 

78) Suzuki Y. and Remington J.S. :  Dual regulation of resistance against Toxoplasma gondii infection by Lyt-2+ and

      Lyt-1+, L3T4+ T cells in mice. Journal of Immunology, vol. 140, no. 11, pp. 3943–3946, 1988.

 

79) Suzuki Y., Orellana M.A., Schreiber R.D., Remington J.S. : Interferon-gamma: the major mediator of resistance against         Toxoplasma gondii. Science. 1988 Apr 22;240(4851):516-8.

 

80) Syn Genevieve, Anderson Denise and Blackwell Jenefer M.: Toxoplasma gondii Infection Is Associated with                            Mitochondrial Dysfunction in Vitro. Front Cell Infect Microbiol. 2017;7:512 Published online 2017 Dec 12.

 

81) Torrey E.F., Bartok J.J., Yolken R.H.:  Toxoplasma gondii and other risk factors for schizophrenia an update.                              Schizophren Bull. 2012; 38(3): 642-647

 

82) Torrey E.F., Yolken R.H.: Toxoplasma oocysts as a public health problem. Trends in Parasitology 2013 Aug;29 (8):                    380-4. Doi: 10.1016/ j.pt.2013.06.001. Epub 2013 Jul 9.

 

83) Townsend J.J., Wolinsky J.S., Baringer J.R., Johnson P.C.:  Acquired toxoplasmosis. A neglected cause of treatable                  nervous system disease. Arch Neurol. 1975 May;32(5):335–343.

 

84) Watts E., Zhao Y., Dhara A., Eller B., Patwardhan A.R. and Anthony P.S.: Novel Approach Reveal that Toxoplasma gondii          Bradyzoites within Tissue Cysts Are Dynamic and Replicating Entities in Vivo (2015). Microbiology, Immunology and              Molecular Genetics Faculty Publi-cations. Paper 67

 

85) Weiss, Louis M. and Dubey, Jitender P.:  Toxoplasmosis: A history of clinical observation Int J parasitol 2009 Jul 1:

       39(8): 895-901

 

86) Weiss, LM, Perlman DC, Sherman J, Tanowitz H, Wittner M. Isospora belli infection: treatment with pyrimethamine. Ann        Intern Med. Sep 15, 1988; 109(6):474-475. Available at pubmed/3261956. www.ncbi.nlm.nih.gov

 

87) White PD.  What Causes Prolonged Fatigue after Infectious Mononucleosis: And Does It Tell Us Anything about Chronic          Fatigue Syndrome? J. Infect Dis 2007;196:4–5

 

88) Wilking H., Thamm M., Stark K., Aebischer T. and Seeber F.: Prevalence, incidence estimations, and risk factors of                 Toxoplasma gondii infection in Germany: a representative, cross-sectional, serological study  In: Nature.com /

      Scientific Reports 6, Article number: 22551 (2016)

 

89) Wolf A, Cowen D. Granulomatous encephalomyelitis due to a protozoan (Toxoplasma or Encephalitozoon). Identifi-               cation of a case from the literature. Bull Neur Inst NY. 1938;7:266–290.

 

90) Wolf A, Cowen D, Paige B. Human toxoplasmosis: occurrence in infants as an encephalomyelitis verification by

       transmission to animals. Science. 1939A;89:226–227.

 

91) Yagmur F., Yasar S., Ozcan Temel H., Cavusoglu M.:  May Toxoplasma gondii increase suicide attempt ? - preliminary              results in Turkish subjects Forens Sci Int. 2010; 199: 15-17

 

92) Yolken R.H., Bachmann S., Ruslanova I., Lillehoj E., Ford G., Torrey E.F., Schroeder J.:  Antibodies to Toxoplasma gondii          in individuals with first-episode schizophrenia. Clin Infect Dis 2001 Mar 1; 32(5):842

 

93) Xiao J., Prandovszky E., Kannan G., Pletnikov M.V., Dickerson F., Severance E.G., Yolken R.H. : Toxoplasma gondii:                   Biological Parameters of the Connection to Schizophrenia.   Schizophr Bull. 2018 Aug 20;44(5):983-992.

      doi: 10.1093/schbul/sby082.

 

94) Yolken R.H., Torrey E.F.  Are some cases of psychosis caused by micro-bial agents ? A review of the evidence. Mol                  Psychiatry. 2008; 13: 470-479

 

95) Zhang Y.W., Fraser A., Balfour A.H., Wreghitt T.G., Gray J.J., Smith J.E. :  Serological reactivity against cyst and                         tachyzoite antigens of Toxoplasma gondii determined by Fast - Elisa J. J. clin Pathol 1995;48:908-911